Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1984-12-12
1986-05-06
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
424 21, 424 35, 514263, 514962, 514964, A61K 952, A61K 958, A61K 962
Patent
active
045871183
ABSTRACT:
A dry sustained release oral dosage formulation of theophylline and a method of orally administering theophylline is disclosed. The oral formulation is comprised of a capsule which includes upper and lower parts which are connectible and easily separable from each other, and a plurality of micropellets present in the capsule. The micropellets provide sustained release of theophylline when taken by a patient and are comprised of inner seeds coated with a mixture of theophylline and polyvinylpyrrolidone which is further coated with a mixture of ethylcellulose and hydroxypropylcellulose. The oral dosage formulation is administered by separating the upper and lower parts of the capsule and placing the micropellets on a food which is preferably soft to the extent of not requiring chewing and then eating the food with the micropellets thereon. The micropellets have sufficient size so that they can be seen, but are sufficiently small so that they are not easily detected in the mouth in combination with the food and can be swallowed without difficulty.
REFERENCES:
patent: 2811483 (1957-10-01), Aterno et al.
patent: 2853420 (1958-09-01), Lowey
patent: 2928770 (1960-03-01), Bardani
patent: 3080294 (1963-03-01), Shepard
patent: 3081233 (1963-03-01), Enz et al.
patent: 3109775 (1963-11-01), Shepard et al.
patent: 3247066 (1966-04-01), Milosovich
patent: 3344029 (1967-09-01), Berger
patent: 3400185 (1968-09-01), Kohnle et al.
patent: 3835221 (1974-09-01), Fulberth et al.
patent: 3922339 (1975-11-01), Shear
patent: 4016254 (1977-04-01), Seager
patent: 4083943 (1978-04-01), Benedickt
patent: 4085214 (1978-04-01), Higuchi et al.
patent: 4173626 (1979-11-01), Dempski et al.
patent: 4248858 (1981-02-01), Guley et al.
Weinberger, J. Pediatrics 92(1):1-7 Jan. 1978, Theophylline for Treatment of Asthma.
Green et al., J. Pediatrics 98(5):832-834 May 1981 Absorption Characteristics of Sustained Release Theophylline Capsules Administered in Applesauce.
1983 USP-D1-Advice for the Patient, vol. II, pp. 759-760, Jul. 1982 "Xanthines".
1983 USP-D1-Drug Information for the Health Care Provider, vol, I, pp. 921-929, Jul. 1982 "Xanthines".
Key Pharmaceuticals, Inc.
Meloy Sybil
Ort Ronald G.
Rose Shep K.
LandOfFree
Dry sustained release theophylline oral formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry sustained release theophylline oral formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry sustained release theophylline oral formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1573901